[go: up one dir, main page]

DE60123132D1 - Liposomenformulierung mit clobetasol propionate - Google Patents

Liposomenformulierung mit clobetasol propionate

Info

Publication number
DE60123132D1
DE60123132D1 DE60123132T DE60123132T DE60123132D1 DE 60123132 D1 DE60123132 D1 DE 60123132D1 DE 60123132 T DE60123132 T DE 60123132T DE 60123132 T DE60123132 T DE 60123132T DE 60123132 D1 DE60123132 D1 DE 60123132D1
Authority
DE
Germany
Prior art keywords
clobetasol propionate
active ingredient
liposome formulation
liposomes
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60123132T
Other languages
English (en)
Other versions
DE60123132T2 (de
Inventor
Gutierrez Xiomara Perez
Leon Ladyth De La Carid Garcia
La Paz Martin-Viana Nilia De
Gonzalez Aymee Roche
Gonzalez Ignacio Hernandez
Diduk Natalia Albertovna
Cortada Calle Linea Ent Granda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT DE INVEST Y DESARROLLO DE M
Centro de Investigacion y Desarrollo de Medicamentos CIDEM
Original Assignee
CT DE INVEST Y DESARROLLO DE M
Centro de Investigacion y Desarrollo de Medicamentos CIDEM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT DE INVEST Y DESARROLLO DE M, Centro de Investigacion y Desarrollo de Medicamentos CIDEM filed Critical CT DE INVEST Y DESARROLLO DE M
Publication of DE60123132D1 publication Critical patent/DE60123132D1/de
Application granted granted Critical
Publication of DE60123132T2 publication Critical patent/DE60123132T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60123132T 2000-07-17 2001-07-17 Liposomenformulierung mit clobetasol propionate Expired - Lifetime DE60123132T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU1712000 2000-07-17
CU20000171A CU23175A1 (es) 2000-07-17 2000-07-17 Formulacion liposomica de propionato de clobetasol
PCT/CU2001/000005 WO2002007702A2 (es) 2000-07-17 2001-07-17 Formulación liposómica de propionato de clobetasol

Publications (2)

Publication Number Publication Date
DE60123132D1 true DE60123132D1 (de) 2006-10-26
DE60123132T2 DE60123132T2 (de) 2007-04-12

Family

ID=40134847

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123132T Expired - Lifetime DE60123132T2 (de) 2000-07-17 2001-07-17 Liposomenformulierung mit clobetasol propionate

Country Status (13)

Country Link
EP (1) EP1360958B1 (de)
CN (1) CN100346773C (de)
AT (1) ATE339188T1 (de)
AU (2) AU2001276254B2 (de)
BR (1) BR0112553A (de)
CA (1) CA2416731C (de)
CU (1) CU23175A1 (de)
DE (1) DE60123132T2 (de)
DK (1) DK1360958T3 (de)
ES (1) ES2272508T3 (de)
HK (1) HK1071070A1 (de)
MX (1) MXPA03000207A (de)
WO (1) WO2002007702A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
ATE328002T1 (de) 1999-10-13 2006-06-15 Univ Johns Hopkins Med Verbindungen zur regulierung des hedgehog- signalwegs, zusammensetzungen und verwendungen davon
DE60113733T2 (de) * 2001-07-02 2006-06-29 Tas, Sinan Verwendung von cyclopamine, zur behandlung des basalzellkarzinoms und anderer tumoren
EP1411938B1 (de) 2001-07-02 2005-07-06 Tas, Sinan Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
WO2017037663A1 (en) 2015-09-02 2017-03-09 Cadila Healthcare Limited Topical compositions comprising corticosteroids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
DK0625899T3 (da) * 1992-02-12 1996-06-17 Janssen Cilag S P A Liposom-itraconazolformuleringer

Also Published As

Publication number Publication date
CA2416731C (en) 2009-12-15
CN1547465A (zh) 2004-11-17
ATE339188T1 (de) 2006-10-15
ES2272508T3 (es) 2007-05-01
WO2002007702A2 (es) 2002-01-31
CU23175A1 (es) 2006-09-22
WO2002007702A3 (es) 2003-07-31
AU7625401A (en) 2002-02-05
DE60123132T2 (de) 2007-04-12
DK1360958T3 (da) 2007-01-29
CA2416731A1 (en) 2003-01-16
EP1360958A2 (de) 2003-11-12
CN100346773C (zh) 2007-11-07
EP1360958B1 (de) 2006-09-13
HK1071070A1 (en) 2005-07-08
BR0112553A (pt) 2003-06-24
MXPA03000207A (es) 2004-09-13
AU2001276254B2 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
US20240115707A1 (en) Dna repair composition
Schmid et al. Therapeutic progress with topical liposome drugs for skin disease
JP2947668B2 (ja) 固体脂質粒子の懸濁液を含有する局所製剤
CN1129425C (zh) 药用的薄页纸产品
EP1138323A3 (de) Resveratrol zur Behandlung von schuppendem Ekzem, Akne oder Psoriasis
ATE237311T1 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
CA1261757A (en) Compositions for treating acne vulgaris and methods of making and using same
CA2175472A1 (en) Propylene glycol stearate vesicles
ES2599973T3 (es) Una formulación tópica de propionato de clobetasol de nivel bajo para tratar trastornos de la membrana mucosa y de la piel
Mezei Liposomes and the skin
CA2196780A1 (en) A liposomal delivery system comprising cationic lipopolyamines and neutral lipids for delivery of biologically active agents
JP2007508243A (ja) 両親媒性コポリマーゲル化剤を含む泡坦体
WO2002076427A3 (en) Ph sensitive liposomal drug delivery
NO962972D0 (no) Preparat for perkutan absorpsjon
KR20110117653A (ko) 국소 발포 조성물 및 도포 방법
ES2319271T3 (es) Uso de totarol para el tratamiento del prurito.
DE60123132D1 (de) Liposomenformulierung mit clobetasol propionate
US20060088497A1 (en) Topical skin care composition
Korting et al. Topical liposome drugs to come: what the patent literature tells us: a review
Banerjee Nanocosmetics: The good, the bad and the beautiful
WO2001041706A2 (en) Lipid nanotubules for topical delivery
Rudy et al. Percutaneous absorption of topically applied medication.
JPH04338319A (ja) 養毛化粧料
ATE179070T1 (de) Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren
EP0815842A3 (de) Arzneimittel und Kosmetika enthaltend Zizyphus-spina-christi Extrakte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition